23h
CD Bioparticles Announces Advanced Engineering Platform for OMV-Based Bacterial Vaccine Development
CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and ...
McGill researchers have developed a diagnostic system capable of identifying bacteria—and determining which antibiotics can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results